Ironwood Pharmaceuticals | IRWD - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Almirall EUR 747.1M 33.12M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amarin USD 602.76M 23.26M 2026-06
Ardelyx USD 381.87M 447K 2026-03
Astellas Pharma JPY 1.42T 19.35B 2026-03
AstraZeneca USD 27.97B 1.65B 2026-06
Charles River Laboratories USD 1.49B 41.76M 2026-03
Coherus Biosciences USD 206.71M 254.25M 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Halozyme Therapeutics USD 1B 177.83M 2026-03
Incyte USD 6.03B 542.31M 2026-06
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
MacroGenics USD 182.52M 37.42M 2026-03
Moderna USD 5.77B 774M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
Pacira USD 514.96M 33.01M 2026-03
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Takeda JPY 3.15T 59.77B 2026-06
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12